Remission induced by a new specific oral polymeric diet in children with Crohn's disease
- PMID: 11490622
- DOI: 10.1159/000061787
Remission induced by a new specific oral polymeric diet in children with Crohn's disease
Abstract
We have been able to show that CT3211 is an effective oral treatment in children with active Crohn's disease. It was well tolerated, and there were minimal side effects. At the mucosal site of disease there was macroscopic and histological improvement, together with evidence of downregulation of the pro-inflammatory cytokines IL-1 beta, IL-8, and IFN-gamma.